BIOM'UP
Biom'Up, expert in the field of resorbable biomaterials, designs, develops and manufactures unique medical devices based on collagen technology. These innovative and clinically proven products cover many different surgical specialties - orthopaedics, spinal, cardiac, general and maxillo-facial - and improve patient healing by allowing guided regeneration of soft tissues and bone.
BIOM'UP
Industry:
Biotechnology Health Care Manufacturing Medical Device
Founded:
2005-01-01
Address:
Saint-priest-ligoure, Limousin, France
Country:
France
Website Url:
http://www.biomup.com
Total Employee:
51+
Status:
Active
Contact:
+33 (0)4 86 57 36 10
Total Funding:
70.84 M EUR
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy DNS Person Schema Gravatar Profiles WP Engine MailChimp SPF
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Biom'Up
Gimv
Gimv investment in Series C - Biom'Up
Lundbeckfonden Ventures
Lundbeckfonden Ventures investment in Series C - Biom'Up
Bpifrance
Bpifrance investment in Series C - Biom'Up
ACG Management
ACG Management investment in Series C - Biom'Up
Aquasourca
Aquasourca investment in Series B - Biom'Up
Sofimac Investment Managers
Sofimac Investment Managers investment in Series B - Biom'Up
Sham
Sham investment in Series B - Biom'Up
Merieux Developpement
Merieux Developpement investment in Series B - Biom'Up
Official Site Inspections
http://www.biomup.com
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Biom'Up"
Biom'Up - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +33 (0)4 86 57 36 10 Biom'Up, expert in the field of resorbable biomaterials, designs, develops and manufactures unique medical devices …See details»
Biom'Up Company Profile 2024: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Biom'Up. Use the PitchBook Platform to explore the full profile.See details»
Biom'Up Company Profile - Office Locations, Competitors ... - Craft
Oct 8, 2020 Biom'Up has 2 employees across 2 locations, $74.59 m in total funding, and €1.18 m in annual revenue in FY 2018. See insights on Biom'Up including office locations, …See details»
Biom’up Finalizes U.S. Commercial Organization to Support
May 2, 2018 Biom'up Chief Financial Officer Jean-Yves Quentel [email protected] +33 4 86 57 36 10: NewCap Investor relations Tristan Roquet Montégon [email protected]See details»
Biom'up USA, Inc - LinkedIn
Biom'up USA, Inc | 886 followers on LinkedIn. Innovative Biosurgery | Founded in 2005, Biom'up, a specialist in collagen-based absorbable medical devices for biosurgery, is developing a new ...See details»
Biom'Up - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Biom'Up . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 5. Number of Board …See details»
Biom'Up - Funding, Financials, Valuation & Investors - Crunchbase
Biom'Up is a French company that specialises in the manufacture of re-absorbable medical devices based on collagen technology.See details»
☑️Biom'Up — Consulting Organization from France, experience …
Oct 11, 2024 Biom'Up — Consulting Organization from France, has experience with Horizon 2020 (2014 - 2020), it`s involved in Health sector. Our website uses cookies to enable …See details»
Biom'up appoints George Makhoul as Chief Commercial Officer …
Jan 31, 2019 SAINT-PRIEST, FRANCE / ACCESSWIRE / January 31, 2019 / Biom'up (PARIS: BUP.PA) (the « Company »), specializing in surgical hemostasis, today announced the …See details»
Biom’up appoints George Makhoul as Chief Commercial Officer …
The commitment to excellence from everyone in the organization positions us for disruptive and exponential growth in the hemostasis market.» ... [email protected] +33 6 64 18 99 59. …See details»
Biom'Up - The Lundbeck Foundation
Biom’Up develops and commercializes hemostatic products based on patented biopolymer designed to simplify surgeons’ practices for open surgical procedures in numerous specialties …See details»
Biom'up reports 2018 full-year results and provides a business …
Apr 30, 2019 SAINT-PRIEST, FRANCE / ACCESSWIRE / April 30, 2019 / Biom'up (the "Company"), a specialist in surgical hemostasis, today announced its full-year results for the …See details»
Biom’up Granted FDA Approval for Its HEMOBLAST ... - Business …
Jan 22, 2019 Biom’up Chief Financial Officer Jean-Yves Quentel [email protected] +33 4 86 57 36 10 MC Services AG International Investor and Public Relations Anne …See details»
Biom’up finalizes U.S. commercial organization to support U.S.
U.S. team of more than 100 specialist sales representatives & seasoned management in placeSee details»
Biom’up granted FDA approval for its HEMOBLASTTM Bellows
[email protected] +33 4 86 57 36 10. Alizé RP Investor Relations Caroline Carmagnol [email protected] +33 6 64 18 99 59. MC Services AG Public Relations and International …See details»
Athryium-backed Biom'up adds two to C-suite | PE Hub
Sep 2, 2020 Athryium-backed Biom’up adds two to C-suite. Biom'up, a developer of hemostatic products, has named Stéphanie Boileau-Canu as chief financial officer and Emmanuel Zylber …See details»
Biom’Up Receives FDA Marketing Approval for HEMOBLAST
Dec 18, 2017 Biom’Up Jean-Paul Alvès, +33 (0)4 86 57 36 10 Chief Financial Officer [email protected] or NewCap Investor Relations Tristan Roquet Montégon, +33 (0)1 …See details»
DGAP-News: Biom'up granted FDA approval for its ... - Markets …
Jan 22, 2019 [email protected] [email protected] +33 4 86 57 36 10 +49 211 529252-22. Alizé RP Investor Relations Caroline Carmagnol [email protected] …See details»
Recommended Stories - Yahoo Finance
SAINT-PRIEST, FRANCE / ACCESSWIRE / April 15, 2019 / Biom'up SA (the "Company ") (PARIS: BUP), specializing in surgical hemostasis, announces today first sales on the US …See details»
Biom’up granted FDA IDE approval for HEMOSNOW(TM)
Saint-Priest, France, April 24, 2019 - 8h00 (CET) - Biom’up (the « Company »), specializing in surgical hemostasis, announced today that the U.S. Food and Drug Administration (FDA) …See details»